Thrombin Market: How the Business Will Grow in 2026? Prominent Players: Pfizer Inc., Johnson & Johnson Services Inc. and more
Sample PDF Brochure:
• Pfizer Inc.
• Johnson & Johnson Services Inc.
• Shanghai RAAS blood products co. Ltd.
• Japan Blood Products Organization
• Mochida Pharmaceutical Co.
• Other prominent players
In the report, Fortune Business Insights has briefed that an increasing emphasis on clinical trials of thrombin has boosted the global market and it is estimated to expand at a CAGR of 4.1%. As of 2018, The Global Thrombin Market was valued at US$ 535.0 Mn and the forecasted CAGR means that this market will be valued at around US$ 738.7 Mn by the end of 2025.
Thrombosis can be caused due to mere sedentary lifestyle habits such as smoking and some other factors such as heart failures, aging and cancer. Thrombin inhibitors play a major part in delaying blood clotting. The healing properties of thrombin, along with its ability to minimize bleeding during surgical procedures has led to an increase in demand for thrombin over the years.
Widespread Applications of Thrombin to Boost Global Market
Thrombin has come a long way from its conventional use to stop bleeding in small cuts on body parts. Now, thrombin plays a major role in most of the surgeries, worldwide. The clinical efficiency of thrombin has led to its widespread use in the healthcare industry, a key factor enabling growth in the global thrombin market. Thrombin is vastly effective in facilitating surgical hemostasis. Over the years, human thrombin was replaced with bovine thrombin, due to its increased efficiency in surgical procedures.
Bovine-derived thrombin was successfully used in patients with hemodialysis. Bovine thrombin is massively helpful in treating hemorrhages in hemodialysis, where-in an excessive amount of blood is lost.
The extent of blood losses in hemodialysis can lead to various disorders and may also prove fatal in some cases. Thus, bovine-derived thrombin is given huge emphasis and healthcare professionals have prioritized thrombin for treating hemorrhages. The thrombin market is therefore forecast to witness a high demand for bovine-derive thrombin in the coming years.
TOC Followed by:
1.1. Research Scope
1.2. Market Segmentation
1.3. Research Methodology
1.4. Definitions and assumptions
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
4.1 Brand Analysis
4.2 Key IndustryDevelopments - Mergers, Acquisitions, and Partnerships
4.3 Reimbursement Scenario
4.4 Key PerformanceIndicators
Recothrom to Emerge as The Most Widely Used Product Type
As surgical blood loss has been prioritized by surgeons and healthcare professionals worldwide, there is an increasing need for an efficient solution to minimize such severe losses. Recothrom was initially manufactured by a US-based company, ZymoGenetics. After involvement from Bayer Healthcare, Recothrom was later acquired by Baxter International. The 2018 acquisition of Recothrom by Baxter has proved fruitful to the overall market.
As of now, Recothrom is the only drug that has been clinically approved for commercial use as a recombinant thrombin brand. Furthermore, Recothrom finds applications in cases where standard surgical procedures such as suture or cautery are ineffective.
Besides Baxter, there have been significant activities from other companies that have contributed to the growth of the global thrombin market. Attractive business strategies of companies such as Pfizer have had a positive impact on the overall market.
Pfizer’s has emerged as the leading company, backed by high clinical efficiency of its product ‘Thrombin JMI’. Some other companies that are operating in the global thrombin market are Johnson & Johnson Services Inc., Shanghai RAAS Blood Products Co. Ltd., Japan Blood Products Organization, and Mochida Pharmaceutical Co.
Browse Complete Report Details:
Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities
Fortune Business Insights Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune - 411045, Maharashtra, India.
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Thrombin Market: How the Business Will Grow in 2026? Prominent Players: Pfizer Inc., Johnson & Johnson Services Inc. and more here
News-ID: 1781855 • Views: 138
More Releases from Fortune Business Insights
What's driving the Digital Signage Market Growth? Prominent Players: Omnivex Cor …
The digital signage market value was at USD 19.78 billion in 2018, according to the new Fortune Business Insights(TM) report, titled "Digital Signage Market Size, Share & Industry Analysis, By Component (Hardware, Software, Content, and Services), By Deployment (On-Premise, Cloud), By Location (Indoor, Outdoor), By Product Type (Video Walls, Digital Posters, Kiosks, Billboards, and Others), By Industry Vertical (Retail, Corporate, Hospitality, Transportation, Education, Healthcare, Sports and Entertainment, and Others) and
What's driving the Welding Consumables Market Growth? Colfax Corporation, The Li …
As Per the report, the global welding consumables market was valued at USD 13.79 Billion in 2018 and is expected to reach USD 23.28 Billion by 2026, exhibiting a CAGR of 6.8%, says Fortune Business Insights in a report, titled "Welding Consumables Market Size, Share & Industry Analysis, By Type (Stick Electrodes, Solid Wires, Flux-cored Wires and SAW Wires & Fluxes), By Application (Heavy Engineering, Automotive, Railways, Construction, Shipbuilding and
What's driving the Road Transport Refrigeration Market Growth? Ingersoll-Rand (T …
As per the Report by Fortune Business Insights report, titled "Road Transport Refrigeration Unit (Equipment) Market Size, Share and Industry Analysis, By Install Vehicle (Van and Light Truck, Heavy Truck, Trailer), By Mode of Operation (Single Temperature, Multi-Temperature), By Power Source (Vehicle Powered, Self-Powered), By Application (Food and Beverage Products, Pharmaceutical and Other Healthcare Products, Floral Products) and Regional Forecast, 2019-2026", the market size in 2018 was 221.3 thousand units.
Medical Robotic Systems Market 2020 Size, Global Industry Outlook, Share, Trends …
The increasing efficiency of robots in performing complicated tasks such as surgeries is leading to wider adoption of medical robots and thus, boosting the global Medical Robotic Systems Market, says Fortune Business Insights in their new study. The study is titled," Medical Robotic Systems Market: Global Market Analysis, Insights, and Forecast, 2019-2026". According to the report, The Global Medical Robotic Systems Market is presumed to witness an exponential CAGR of
More Releases for Thrombin
Thrombin Market to Reach US$690.1 mn by 2025
Global Thrombin Market: Snapshot Thrombin is serine protease blood plasma protein which converts fibrinogen into soluble fibrin to catalyze blood coagulation process. Globally commercially available therapeutic thrombin products are derived from bovine source, human plasma and genetic recombination (recombinant). Thrombin JMI, Evithrom, Recothrom, Thrombin Mochida, etc. are few approved hemostatic products in the USA and Japan. Thrombin is used in several medical surgeries in management of uncontrolled bleeding. View Report- https://www.transparencymarketresearch.com/thrombin-market.html Thrombin is also
Global Thrombin Market: Demand for Bovine Thrombin to Remain Robust throughout t …
A new informative study titled “Thrombin Market - Global Industry Analysis, Size, Share, Growth, Trends, & Forecast 2017 - 2025” has recently been added to the repository of Market Research Reports Search Engine (MRRSE). According to the report, the global thrombin market is likely to grow at a CAGR of 3.8% during the assessment period. In terms of revenue, the market is likely to surpass US$ 690 Mn in revenues. Download
Global Thrombin Market: Demand for Bovine Thrombin to Remain Robust throughout t …
A new informative study titled “Thrombin Market - Global Industry Analysis, Size, Share, Growth, Trends, & Forecast 2017 - 2025” has recently been added to the repository of Market Research Reports Search Engine (MRRSE). According to the report, the global thrombin market is likely to grow at a CAGR of 3.8% during the assessment period. In terms of revenue, the market is likely to surpass US$ 690 Mn in revenues. Request Sample Copy
Recombinant Thrombin Market to Witness a Pronounce Growth by 2025
Hemostasis is the process where platelets, blood vessels, and coagulation factors act together to arrest bleeding. Hemostasis occurs by the coagulation process where blood is solidified from liquid to gel state through serial enzymatic steps. During the hemostasis process, thrombin plays the role of key enzyme. Thrombin is an enzyme which is synthesized from precursor glycoprotein called prothrombin. During the clotting process, proteolytic cleavage of prothrombin results in thrombin. Insoluble
Anti-thrombin Activators Market Segmentation and Company Analysis to 2024
Anti-thrombin activators are widely accepted due to their role in reducing thrombus formation. Anticoagulants, anti-platelet drugs, and thrombolytic drugs are some of the different types of anti-thrombin activators available, which act by different mechanisms. While anticoagulants restrict blood clotting, thrombolytic drugs are useful in dissolving clots already formed in the human body. Anti-platelet drugs limit platelets aggregation. Anticoagulants can be further divided into direct factor Xa inhibitors, vitamin K
Thrombin Market Size & Share Analysis & Industry Outlook - 2024
Hemostasis is a medical condition, wherein blood vessel, platelets, and coagulation factors act together to arrest bleeding. It occurs by coagulation process, wherein blood is transformed from liquid to gel state through sequential enzymatic steps. During hemostasis process, thrombin plays a role of key enzyme. Thrombin is an enzyme called serine protease, which is synthesized from a precursor glycoprotein called prothrombin. During the clotting process, proteolytic cleavage of prothrombin produces